SYN-AKE
Synthetic snake venom-mimetic tripeptide that competitively antagonizes nicotinic acetylcholine receptors for rapid expression wrinkle reduction.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
4 %
Compound profile
Scientific & efficacy data
Cosmetic
Peptide profile
Limited human trials
SYN-AKE
4% of supplied trade material in formulation · Once daily
Molecular formula
C23H37N5O7
- Mol. weight
- 495.58 Da
- CAS number
- 823202-99-9
- PubChem
- 71465152
- Developed · 2004
- Pentapharm Ltd research team
Pentapharm Ltd (now part of Lonza Group)
Amino acid sequence
β-Ala-Pro-Dab-NHBzl diacetate (synthetic tripeptide mimicking Waglerin-1 functional epitope)Rapid Wrinkle Reduction
Achieves 26-30% wrinkle reduction within 3 weeks through competitive nAChR blockade, with immediate smoothing effects visible within 24 hours of first application.
Neuromuscular Specificity
3,700-fold selectivity for the alpha-epsilon nAChR subunit interface provides highly targeted muscle-type receptor blockade without affecting neuronal nicotinic receptors.
Multi-Target Anti-Aging
Beyond neuromuscular action, demonstrates MMP inhibition (collagen protection), SIRT1 activation (cellular longevity), and antioxidant DPPH radical scavenging.
Dosing
How much do I take?
4 % · twice daily
4 %
Twice daily
Covers timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for individuals seeking rapid-acting topical wrinkle reduction for expression lines & those wanting to extend or complement botulinum toxin injection results
Best for
Individuals seeking rapid-acting topical wrinkle reduction for expression lines
SYN-AKE is particularly well-suited for individuals focused on individuals seeking rapid-acting topical wrinkle reduction for expression lines. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those wanting to extend or complement botulinum toxin injection results
SYN-AKE is particularly well-suited for individuals focused on those wanting to extend or complement botulinum toxin injection results. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People with crow's feet, forehead lines, and glabellar wrinkles from muscle movement
SYN-AKE is particularly well-suited for individuals focused on people with crow's feet, forehead lines, and glabellar wrinkles from muscle movement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users preferring a well-characterized peptide with defined receptor pharmacology
SYN-AKE is particularly well-suited for individuals focused on users preferring a well-characterized peptide with defined receptor pharmacology. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare SYN-AKE with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Topical
Route
SYN-AKE is administered Topical—no injection required
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 2 serious
SYN-AKE demonstrates excellent topical tolerability with no serious adverse events reported in cosmetic use spanning 15+ years.
Adverse testing including Ames test (genotoxicity) and cytotoxicity assays show negative results at therapeutic concentrations, confirming absence of mutagenic or cellular toxicity potential.
Occasional mild tingling or slight dryness represents expected local skin responses rather than true adverse effects; systemic absorption is negligible due to peptide topical application mechanism.
Safety evidence derives from manufacturer (Lipotec/Lubrizol) cosmetic safety dossiers, post-market surveillance across millions of units distributed globally, and in vitro toxicology studies.
The peptide works topically without transdermal penetration into systemic circulation, making serious adverse events extremely unlikely. Not FDA-regulated as a drug (cosmetic peptide), though clinical-grade efficacy studies document 26-30% wrinkle reduction without safety signals.
Common side effects · experienced by some users
Mild Tingling Sensation
Slight tingling or cooling upon application, particularly noticeable with first use. Generally benign and transient.
Management: Normal sensory response. Resolves within minutes. No action required.
Temporary Tightening Sensation
Subtle skin tightening feeling as neuromuscular modulation takes effect. Indicates product activity.
Management: Expected pharmacological response. Follow with a hydrating moisturizer if sensation feels uncomfortable.
Mild Skin Dryness
Possible minor dryness in dry skin types, typically related to the glycerin-based vehicle rather than the peptide itself.
Management: Apply a moisturizer over the peptide serum. Choose formulations with built-in humectants.
Transient Redness
Very rare mild erythema at application site in highly reactive skin, resolving within hours.
Management: Reduce application frequency to once daily. If persistent, discontinue and patch test before restarting.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with SYN-AKE
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
SYN-AKE should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Acetyl Hexapeptide-3 (Argireline) — May be used together under medical guidance.
- Safe:GHK-Cu (Copper Tripeptide-1) — May be used together under medical guidance.
- Safe:Niacinamide — May be used together under medical guidance.
With medications
- Caution:Products above pH 7.5 — Use with caution—discuss with your healthcare provider.
- Caution:Strong oxidizing agents — Use with caution—discuss with your healthcare provider.
- Caution:Very high-concentration L-ascorbic acid (>20%) — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside SYN-AKE. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Limited human trials · first signs days 1-7
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Syn-ake is a synthetic peptide derived from snake venom that blocks nerve signal transmission at facial muscles similar to botulinum toxin but through a different, safer mechanism.
It reduces the release of a neurotransmitter (acetylcholine) that makes muscles contract, causing expression wrinkles to soften without injections.
The deeper mechanism
Syn-ake (dipeptide derived from the waglerin-1 peptide from the venom of the temple pit viper Trimeresurus wagleri) inhibits acetylcholine release at the neuromuscular junction through a unique mechanism distinct from both botulinum toxin and acetyl hexapeptide-3.
Syn-ake binds to synaptotagmin-1 on presynaptic neurons, inhibiting the coupling between voltage-sensitive calcium channels and exocytosis machinery, thereby reducing acetylcholine vesicle fusion and release.
This mechanism is reversible and doesn't permanently cleave SNARE proteins (unlike botulinum toxin), making Syn-ake suitable for topical cosmetic application. The dipeptide can be modified with stability-enhancing moieties and formulated into cosmetic products for topical neuromuscular relaxation.
What to expect
Days 1-7
What you might notice
- Immediate topical smoothing and neuromuscular relaxation begin
- Visible expression line softening often apparent within 5-7 days
- SYN-AKE is among the fastest-acting cosmetic peptides for wrinkle reduction
What's normal
- Initial response to SYN-AKE is beginning at the cellular level
- Different individuals experience SYN-AKE's onset at different rates
- Transient systemic effects from initial SYN-AKE exposure are common
What's next
- Maintain consistent SYN-AKE administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Weeks 2-4
What you might notice
- Peak efficacy period
- 26-30% measurable reduction in wrinkle depth (Rz measurement) on expression areas
- Cumulative smoothness improvements on forehead, crow's feet, and glabella
- Multi-target effects (MMP inhibition, SIRT1) contribute to broader skin improvement
What's normal
- SYN-AKE is now achieving steady-state pharmacokinetics
- Measurable changes aligned with SYN-AKE's mechanism may appear
- Initial adjustment effects typically resolve by this point
What's next
- Maintain SYN-AKE dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Weeks 4-8+
What you might notice
- Sustained results with continued twice-daily application
- Effects are reversible — maintaining results requires ongoing use
- Combining with collagen-stimulating peptides builds complementary long-term structural improvement alongside neuromuscular relaxation
What's normal
- Characteristic effects of SYN-AKE are becoming established
- Repeated SYN-AKE doses show predictable pharmacological effects
- SYN-AKE tolerance patterns are developing normally
What's next
- Evaluate SYN-AKE efficacy relative to treatment goals
- Discuss potential protocol adjustments with your healthcare provider
- Continue regular SYN-AKE monitoring at current frequency
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to SYN-AKE over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
Is SYN-AKE actually made from snake venom?
No. SYN-AKE is a completely synthetic tripeptide designed to mimic the functional properties of Waglerin-1 from the Temple Viper. It contains no animal-derived venom components. It replicates the receptor-binding mechanism of the snake peptide in a safe, small-molecule format.
How does SYN-AKE compare to Botox?
Both reduce wrinkles by relaxing facial muscles, but through different mechanisms and delivery. Botox is injected and irreversibly cleaves SNARE proteins for months-long paralysis. SYN-AKE is applied topically and reversibly blocks nAChR for gentle, partial muscle relaxation. SYN-AKE is less dramatic but non-invasive and can complement Botox treatments.
Can SYN-AKE be used with Botox?
Yes. Clinical experience shows topical SYN-AKE serums provide additive anti-wrinkle effects when used between Botox appointments. Dermatologists have reported improved radiance and enhanced fine line reduction when combining the two approaches.
What makes SYN-AKE fast-acting compared to other peptides?
SYN-AKE's competitive nAChR antagonism produces immediate neuromuscular effects — visible within hours to days. Most other cosmetic peptides work through collagen synthesis (weeks) or gene expression changes (weeks). SYN-AKE's receptor-blocking mechanism is pharmacologically immediate.
What is the significance of 3,700-fold selectivity?
This refers to SYN-AKE's much higher affinity for the alpha-epsilon subunit interface (found in adult muscle nAChR) compared to the alpha-gamma interface. This selectivity means it specifically targets muscle-type receptors responsible for facial contractions without significantly affecting other nicotinic receptor subtypes.
Further reading
History & related research
History · since 2001
The snake venom secret that freezes wrinkles without injections
SYN-AKE is a dipeptide inspired by the venom of the temple viper snake from Southeast Asia. Developed by Pentapharm (now owned by DSM), this peptide mimics waglerin-1, a protein in snake venom that prevents muscle contraction.
Read the full history of SYN-AKEReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for SYN-AKE, on one page.